|
Apr 4
|
Basilea announces US FDA approval of antibiotic ZEVTERA® (ceftobiprole medocaril) for three indications
|
|
Jan 15
|
Basilea announces acquisition of preclinical antibiotics program from Spexis
|
|
Dec 20
|
Basilea announces accelerated loan repayment
|
|
Oct 2
|
Basilea announces FDA acceptance of New Drug Application for antibiotic ceftobiprole
|